Clinical Trials Browser

Phase 1/2 × Locally Advanced Unresectable Gastric Adenocarcinoma × Ramucirumab × Clear all

NCT03739801 2020-03-27

MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Phase 1/2 Withdrawn

Gastrointestinal

Locally Advanced Unresectable Gastric Adenocarcinoma